Product
[212Pb]Pb-ADVC001
1 clinical trial
2 indications
Indication
Prostate CancerIndication
Castration-ResistantClinical trial
TheraPb: Phase I/IIa Dose Escalation and Toxicity Study of [212Pb]Pb-ADVC001 in Metastatic Prostate AdenocarcinomaStatus: Recruiting, Estimated PCD: 2024-06-01